Onward Medical N.V. (EBR:ONWD)

Market Cap	255.28M
Revenue (ttm)	-188.00K
Net Income (ttm)	-35.15M
Shares Out	44.63M
EPS (ttm)	-1.09
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	16,191
Average Volume	91,386
Open	5.86
Previous Close	5.84
Day's Range	5.78 - 5.90
52-Week Range	4.30 - 7.24
Beta	0.87
RSI	41.45
Earnings Date	Mar 31, 2025

About Onward Medical

Onward Medical N.V., a medical technology company, develops implantable neuro-stimulation Systems and non-invasive systems for electrical stimulation of specific areas of the spinal cord. The company engages in developing ARCEX, a transcutaneous system designed to improve upper extremity strength, function, and other symptoms in people with spinal cord injury (SCI); ARCIM, a minimally invasive implantable system to address blood pressure instability and other symptoms in people with SCI; and ARCBCI, which adds an implantable bran-computer inter...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2014
• Employees: 99
• Stock Exchange: Euronext Brussels
• Ticker Symbol: ONWD

Financial Performance

In 2023, Onward Medical's revenue was 532,000, a decrease of -75.23% compared to the previous year's 2.15 million. Losses were -36.18 million, 10.4% more than in 2022.